Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “SARS Coronavirus (SARS-CoV-2) Infection”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04416334
What this trial is testing

PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS

Who this might be right for
SARS-CoV-2 Infection (COVID-19)
Instituto de Investigación Marqués de Valdecilla 70
Testing effectiveness (Phase 2)Ended earlyNCT04343755
What this trial is testing

Convalescent Plasma as Treatment for Hospitalized Subjects With COVID-19 Infection

Who this might be right for
COVID-19
Hackensack Meridian Health 52
Not applicableStudy completedNCT04815304
What this trial is testing

Clinical Features of COVID-19 Patients

Who this might be right for
Covid19Acute Respiratory Distress SyndromeVentilatory Failure
San Salvatore Hospital of L'Aquila 200
Large-scale testing (Phase 3)UnknownNCT05225285
What this trial is testing

Efficacy, Immunogenicity and Safety of Inactivated Vaccine (Coronavac) Against SARS-COV2 in Children and Adolescents

Who this might be right for
COVID-19
Federal University of Espirito Santo 1,120
Large-scale testing (Phase 3)UnknownNCT05216484
What this trial is testing

Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)

Who this might be right for
SARS-CoV-2 Infection
Chinese Academy of Medical Sciences 480
Large-scale testing (Phase 3)WithdrawnNCT04610801
What this trial is testing

Evaluation of the Efficacy of Xylitol Nasal Spray Against SARS-CoV-2

Who this might be right for
Covid19
Larkin Community Hospital
Early research (Phase 1)WithdrawnNCT05596045
What this trial is testing

Study to Evaluate Safety, Tolerability, Efficacy and Pharmacokinetics of ASC10 in Mild to Moderate COVID-19 Patients

Who this might be right for
SARS CoV 2 Infection
Ascletis Pharmaceuticals Co., Ltd.
Early research (Phase 1)UnknownNCT05085639
What this trial is testing

GLS-5310 Vaccine in Healthy Volunteers for the Prevention of SARS-CoV-2 (COVID-19)

Who this might be right for
Covid19Healthy
GeneOne Life Science, Inc. 30
Large-scale testing (Phase 3)Study completedNCT04356495
What this trial is testing

Trial of COVID-19 Outpatient Treatment in Individuals With Risk Factors for Aggravation

Who this might be right for
Corona Virus InfectionSars-CoV2
University Hospital, Bordeaux 412
Not applicableStudy completedNCT05548829
What this trial is testing

COVID RESPONSE STUDY (COVRES)

Who this might be right for
COVID-19
University of Ulster 519
Testing effectiveness (Phase 2)Study completedNCT04354831
What this trial is testing

Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients

Who this might be right for
COVID-19
Medical College of Wisconsin 131
Testing effectiveness (Phase 2)Ended earlyNCT04668339
What this trial is testing

A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults

Who this might be right for
Covid19SARS-CoV InfectionCorona Virus Infection
Arcturus Therapeutics, Inc. 581
Post-approval studies (Phase 4)Ended earlyNCT04757857
What this trial is testing

COVID-19 Antithrombotic Rivaroxaban Evaluation

Who this might be right for
COVID-19
Hospital Alemão Oswaldo Cruz 660
Not applicableStudy completedNCT04567927
What this trial is testing

Prevalence and Risk Factors for Venous Thromboembolic Events in Critically Ill Patients With COVID-19

Who this might be right for
SARS Virus
Chiesa Alessandro Felice 80
Not applicableStudy completedNCT04928469
What this trial is testing

Clinical Impact of COVID-19 by P.1 SARS-CoV-2 Lineage

Who this might be right for
Covid19COVID-19 PneumoniaSARS-CoV-2 Infection
Hospital de Clinicas de Porto Alegre 86
Not applicableStudy completedNCT05289141
What this trial is testing

Interest in the Use of Nasal High-Flow Oxygen Therapy (OptiFlow™) in Secondary Transport of COVID-19 Positive Patients

Who this might be right for
COVID-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 229
Large-scale testing (Phase 3)Study completedNCT04941105
What this trial is testing

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19

Who this might be right for
Sars-CoV-2 Infection
Collegium Medicum w Bydgoszczy 60
Testing effectiveness (Phase 2)Study completedNCT05210101
What this trial is testing

A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals

Who this might be right for
SARS CoV 2 Infection
Sophia Koo, M.D. 93
Large-scale testing (Phase 3)Looking for participantsNCT06928272
What this trial is testing

Long Covid (LC)-REVITALIZE - A Long Covid Repurposed Drug Study

Who this might be right for
Long COVID
Douglas D. Fraser 348
Not applicableStudy completedNCT04912895
What this trial is testing

Detection of SARS-CoV-2 RNA in Coughed Droplets From Patients With COVID-19

Who this might be right for
Covid19
Emory University 69
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation